Table 1 The clinicopathologic characteristics of all patients
Characteristic | RSCC | LSCRC | P value |
|---|---|---|---|
Sex | Â | Â | 0.107 |
 Male | 30 (60%) | 104 (72.2) |  |
 Female | 20 (40%) | 40 (28.8) |  |
Age | 55.50 (23–75) | 60 (20–75) | 0.311 |
Liver metastasis | Â | Â | 0.293 |
 Single lesion | 8 (16%) | 15 (10.4) |  |
 Multiple lesions | 42 (84%) | 129 (89.6) |  |
Diameter of liver metastasis | Â | Â | 0.644 |
 <3 cm | 20 (40%) | 63 (43.8%) |  |
 ≥3 cm | 30 (60%) | 81 (56.2%) |  |
CEA (ng/ml) | Â | Â | 0.646 |
 <200 | 40 (80%) | 105 (72.9%) |  |
 ≥200 | 10 (20%) | 39 (27.1%) |  |
CA199 (U/ml) | Â | Â | 0.644 |
 <35 | 20 (40%) | 63 (43.8%) |  |
 ≥35 | 30 (60%) | 81 (56.2%) |  |
Systemic chemotherapy | Â | Â | 0.194 |
 No | 10 (20) | 18 (5.6%) |  |
 Yes | 40 (80) | 126 (94.4%) |  |
Target agent | Â | Â | 0.970 |
 None | 39 (78%) | 109 (75.7%) |  |
 C225 | 5 (10%) | 12 (8.3%) |  |
 Avastin | 4 (8%) | 15 (10.4%) |  |
 Both | 1 (2%) | 4 (2.8%) |  |
 Other | 1 (2%) | 4 (2.8%) |  |